5.245 bedrijven voldoen
Showing 5.001–5.050 of 5.245
| Bedrijf | Cijfer | Koers | Onder top | K/W | Grootte | Rend. | Opties | Sector |
|---|---|---|---|---|---|---|---|---|
| F- | US$ 0,20 | -100% | — | US$ 3,6M | — | — | Software Application | |
| D- | US$ 1,73 | -67% | — | US$ 3,6M | — | — | Building Products and Equipment | |
| B- | US$ 0,15 | -100% | — | US$ 3,5M | — | — | Security and Protection Services | |
| F | US$ 1,46 | -96% | — | US$ 3,5M | — | — | Packaged Foods | |
| F | US$ 0,73 | -70% | — | US$ 3,5M | — | — | Farm and Heavy Construction Machinery | |
| D- | US$ 1,30 | -94% | — | US$ 3,4M | — | — | Real Estate Development | |
| F- | US$ 1,63 | -94% | — | US$ 3,4M | — | — | Business Equipment and Supplies | |
| Geen cijfer | US$ 2,25 | -94% | — | US$ 3,4M | — | — | Drug Manufacturers Specialty and Generic | |
| Geen cijfer | US$ 6,27 | -65% | — | US$ 3,4M | — | — | Biotechnology | |
| D- | US$ 1,32 | -95% | — | US$ 3,4M | — | — | Software Application | |
| Geen cijfer | US$ 0,45 | -68% | — | US$ 3,4M | — | — | Biotechnology | |
| Geen cijfer | US$ 7,77 | -45% | — | US$ 3,3M | 5,7% | — | — | |
| D | US$ 2,20 | -80% | — | US$ 3,3M | — | — | Capital Markets | |
| D- | US$ 0,51 | -100% | — | US$ 3,3M | — | — | Specialty Industrial Machinery | |
| D- | US$ 0,15 | -90% | — | US$ 3,3M | — | — | Health Information Services | |
| F- | US$ 0,09 | -93% | — | US$ 3,2M | — | Maandelijks | Real Estate Services | |
| F- | US$ 2,22 | -98% | — | US$ 3,2M | — | — | Agricultural Inputs | |
| F- | US$ 1,97 | -88% | — | US$ 3,2M | — | — | Auto Manufacturers | |
| C- | US$ 0,49 | -84% | — | US$ 3,2M | — | — | Software Application | |
| F- | US$ 1,66 | -100% | — | US$ 3,2M | — | — | Integrated Freight and Logistics | |
| Geen cijfer | US$ 1,85 | -96% | — | US$ 3,1M | — | — | Biotechnology | |
| C | US$ 0,91 | -100% | — | US$ 3,1M | — | — | Health Information Services | |
| C | US$ 5,54 | -94% | — | US$ 3,1M | — | — | Farm Products | |
| F | US$ 0,36 | -72% | — | US$ 3,1M | — | — | Biotechnology | |
| F- | US$ 1,11 | -78% | — | US$ 3,1M | — | — | Reit Diversified | |
| F- | US$ 0,84 | -59% | — | US$ 3,1M | — | — | Advertising Agencies | |
| D- | US$ 2,11 | -60% | — | US$ 3M | — | — | Security and Protection Services | |
| C | US$ 0,22 | -97% | — | US$ 3M | — | Maandelijks | Medical Devices | |
| B | US$ 0,56 | -100% | — | US$ 3M | — | — | Restaurants | |
| Geen cijfer | US$ 4,28 | -87% | — | US$ 2,9M | — | — | Biotechnology | |
| F- | US$ 0,57 | -48% | — | US$ 2,9M | — | — | Real Estate Services | |
| Geen cijfer | US$ 0,59 | -82% | — | US$ 2,9M | — | — | Biotechnology | |
| F- | US$ 1,83 | -82% | — | US$ 2,9M | — | — | Biotechnology | |
| D- | US$ 0,32 | -98% | — | US$ 2,9M | — | Maandelijks | Specialty Industrial Machinery | |
| B- | US$ 2,43 | -69% | — | US$ 2,9M | — | — | Integrated Freight and Logistics | |
| F- | US$ 2,96 | -100% | — | US$ 2,8M | — | — | Drug Manufacturers Specialty and Generic | |
| D- | US$ 0,17 | -92% | — | US$ 2,8M | — | — | Software Infrastructure | |
| D- | US$ 1,23 | -78% | — | US$ 2,8M | — | — | Integrated Freight and Logistics | |
| F- | US$ 0,92 | -82% | — | US$ 2,7M | — | — | Specialty Chemicals | |
| D- | US$ 0,25 | -98% | — | US$ 2,7M | — | — | Medical Devices | |
| F- | US$ 0,11 | -96% | — | US$ 2,7M | — | — | Trucking | |
| D- | US$ 1,07 | -93% | — | US$ 2,7M | — | — | Engineering and Construction | |
| F- | US$ 0,21 | -85% | — | US$ 2,6M | — | — | Security and Protection Services | |
| F | US$ 0,21 | -99% | — | US$ 2,6M | — | — | Medical Devices | |
| F- | US$ 2,61 | -92% | — | US$ 2,6M | — | — | Insurance Brokers | |
| Geen cijfer | US$ 0,31 | -95% | — | US$ 2,6M | — | — | Computer Hardware | |
| Geen cijfer | US$ 0,22 | -98% | — | US$ 2,5M | — | — | Beverages Wineries and Distilleries | |
| D | US$ 0,04 | -98% | — | US$ 2,5M | — | — | Software Application | |
| F- | US$ 1,06 | -100% | — | US$ 2,5M | — | — | Auto Manufacturers | |
| D- | US$ 6,69 | -48% | — | US$ 2,5M | — | — | Reit Specialty |
Een filter is geen aanbeveling. Elke regel voldeed aan de genoemde test en niets meer — InspectStocks beschrijft bedrijven op basis van hun eigen SEC-indieningen en adviseert niet om iets te kopen of te verkopen.